Journal
BREAST
Volume 20, Issue -, Pages S3-S11Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.breast.2011.02.006
Keywords
Breast cancer; Low income countries; Community awareness; Treatment; Diagnosis; Palliative care
Categories
Funding
- Fred Hutchinson Cancer Research Center
- Susan G. Komen for the Cure [SG09-0605-01-BHGI]
- U.S. Office of International Affairs, National Cancer Institute
- European School of Oncology
- Pan American Health Organization
- Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer
- American Society of Clinical Oncology
- LIVESTRONG
- U.S. Centers for Disease Control and Prevention
- U.S. Office of Women's Health, Department of Health and Human Services
- U.S. Office of Science Planning and Assessment, National Cancer Institute
- U.S. Office of Research on Women's Health, National Institutes of Health
- GE Healthcare
- sanofi-aventis
- Breast Health Global Initiative (BHGI)
- Bayer Sherling Pharma
- Breast Cancer Research Foundation (BCRF)
- ASCO
- UICC
- ESMO
- RWC
- University of Washington
- Genentech
- AstraZeneca
- Genentech - Amgen
- Novartis - Roche
Ask authors/readers for more resources
The Breast Health Global Initiative (BHGI) brought together international breast cancer experts to discuss breast cancer in low resource countries (LRCs) and identify common concerns reviewed in this consensus statement. There continues to be a lack of public and health care professionals' awareness of the importance of early detection of breast cancer. Mastectomy continues to be the most common treatment for breast cancer; and a lack of surgeons and anesthesia services was identified as a contributing factor in delayed surgical therapy in LRCs. Where available, radiation therapy is still more likely to be used for palliation rather than for curative treatment. Tumor receptor status is often suboptimally performed due to lack of advanced pathology services and variable quality control of tissue handling and processing. Regional pathology services can be a cost-effective approach and can serve as reference, training and research centers. Limited availability of medical oncologists in LRCs often results in non-specialist providing chemotherapeutic services, which requires additional supervision and training. Palliative care is an emerging field in LRCs that requires investment in training and infrastructure development. A commitment and investment in the development of breast cancer care services by LRC governments and health authorities remains a critical need in LRCs. (C) 2011 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available